Azenta (AZTA) Expected to Announce Quarterly Earnings on Wednesday

Azenta (NASDAQ:AZTA) is anticipated to post its quarterly earnings results before the market opens on Wednesday, February 5th. Analysts expect Azenta to post earnings of $0.05 per share and revenue of $145.69 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. Azenta’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period last year, the business earned $0.13 EPS. On average, analysts expect Azenta to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Azenta Price Performance

Shares of Azenta stock opened at $52.09 on Tuesday. The company has a 50-day moving average of $50.09 and a 200 day moving average of $49.04. The firm has a market cap of $2.38 billion, a price-to-earnings ratio of -17.54 and a beta of 1.47. Azenta has a 1 year low of $38.82 and a 1 year high of $67.77.

Analysts Set New Price Targets

A number of analysts have weighed in on AZTA shares. Stephens restated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a research note on Thursday, January 2nd. Needham & Company LLC reduced their price objective on shares of Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th.

Insider Buying and Selling

In related news, CEO John Marotta acquired 12,717 shares of Azenta stock in a transaction dated Monday, November 18th. The shares were purchased at an average price of $39.48 per share, for a total transaction of $502,067.16. Following the completion of the transaction, the chief executive officer now directly owns 99,612 shares in the company, valued at approximately $3,932,681.76. This represents a 14.63 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William L. Cornog purchased 12,500 shares of Azenta stock in a transaction that occurred on Monday, November 18th. The stock was acquired at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the transaction, the director now directly owns 14,755 shares of the company’s stock, valued at $584,298. The trade was a 554.32 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have sold 1,423 shares of company stock valued at $57,020. 10.62% of the stock is owned by insiders.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.